OraSure Technologies

OraSure Technologies, Inc. is a global healthcare company based in Bethlehem, Pennsylvania. The company specializes in diagnostic tests, sample collection devices, and related health solutions. It operates through several subsidiaries, including DNA Genotek, Diversigen, UrSure, and Novosanis, providing comprehensive health solutions. OraSure develops rapid diagnostic tests for infectious diseases such as HIV, Hepatitis C, Ebola, Zika, and influenza. The company also offers oral fluid diagnostic devices and non-invasive sample collection kits. Additionally, it provides immunoassay tests for insurance risk assessment, substance-abuse testing, and forensic toxicology. Their product line includes cryosurgical devices for wart removal and benign skin lesion treatment. The company serves a diverse customer base, including hospitals, clinics, public health organizations, and clinical laboratories across the globe. Its products are distributed through partners in the Americas, Europe, and Asia-Pacific. Recently, OraSure reported growth in point-of-need and home diagnostic solutions, reflecting its commitment to advancing healthcare.